logo
welcome
The Daily

The Daily

Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease

The Daily
Summary
Nutrition label

88% Informative

Semaglutide is a glucagon-like peptide receptor (GLP-1R) molecule that decreases hunger and helps regulate blood sugar in T2D.

About 120,000 Americans die from Alzheimer’s disease each year, with the disease listed as seventh -leading cause of death nationally.

VR Score

91

Informative language

93

Neutral language

46

Article tone

formal

Language

English

Language complexity

79

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links